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Abstract
We evaluated the ability of high-intensity visible violet light with a peak output of 405 nm to kill 
epidemiologically important pathogens. The high irradiant light significantly reduced both 
vegetative bacteria and spores at some time points over a 72-hour exposure period.
Over the last decade, substantial scientific evidence suggests that the hospital environment is 
an important source of organisms that, when transmitted, can cause healthcare-associated 
infections for several reasons.1 First, the hospital environment is commonly contaminated 
with epidemiologically important healthcare pathogens such as methicillin-resistant 
Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), multidrug-
resistant (MDR) Acinetobacter, and Clostridium difficile.1,2 These pathogens share the 
following general characteristics: (1) devices and surfaces in the patient room are frequently 
contaminated; (2) an ability to survive for prolonged periods of time on environmental 
surfaces (eg, days to months); and (3) contact with surfaces contaminated with these results 
in hand or glove contamination, which may be transferred to patients. Finally, room 
disinfection reduces contamination with these organisms.1–3 Second, standard cleaning and 
disinfection methods are inadequate in most, if not all, hospitals. On average, only 50% of 
surfaces in hospital rooms are cleaned between patients.4 As a result, patients admitted to 
the rooms previously occupied by patients with MDR organisms are at a 39%–353% 
increased risk of subsequent infection (a 120% increased risk on average).4
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An overhead light fixture technology, which continuously and safely disinfects the 
environment using light-emitting diodes (LEDs) by emitting a high-intensity, narrow-
spectrum (HINS) light, has been proposed as an infection prevention strategy.5–7 This 
technology uses LEDs to create a narrow bandwidth of high-intensity visible violet light 
with a peak output of 405 nm. The wavelength of the LEDs is certified by the manufacturer 
to be 405 nm ± 3 nm. This light in turn reacts with porphyrin molecules to generate reactive 
oxygen species that kill microorganisms.5 The purpose of this evaluation was to determine 
the effectiveness of HINS light for the reduction of epidemiologically important pathogens 
in the environment.
Methods
Light source and irradiance
An overhead, visible light disinfection technology (Indigo-Clean, Kenall Manufacturing, 
Kenosha, WI) was evaluated in 2 different clinical configurations. In phase 1 (“white” 
lights), two 61-cm × 61-cm (2-foot × 2-foot) blended-white, ceiling-mounted fixtures were 
used to provide both disinfection and ambient white illumination for use in normal clinical 
conditions in an occupied room. The measured surface irradiance of this “white” 
disinfecting light at the pathogen location was ~ 0.12–0.16 mW/cm2. In phase 2 (“blue” 
light), a higher-level of disinfection light was studied by adding a 61-cm × 122-cm (2-foot × 
4-foot) overhead “blue” light fixture to the 2 preexisting 61-cm × 61-cm overhead, blended-
white fixtures. The measured surface irradiance of disinfecting “blue” light at the pathogen 
location was ~0.34–0.44 mW/cm2. The surface irradiance measurements in the control area 
yielded values of 0.00 mW/cm2 (no measurable disinfecting light). These surface irradiance 
measurements were made using a National Institute of Standards and Technology (NIST)-
calibrated spectroradiometer (model no. USB2000 +, Ocean Optics, Wesley Chapel, FL).
Phase 1 and phase 2 testing were conducted in a 12.5 m2 (134 ft2) room. The room used did 
not have windows or external sources of light. Each of the 3 lights described above were 
connected via separate light switches and were simply switched “on” and “off” at the wall 
switch. Light placement was designed to treat the study room with intensity sufficient to 
cause inactivation of test bacteria. In both phases, the indicated lights were operated 
continuously (ie, 24 hours per day, 7 days per week) during the sampling period, and no 
other lights were present in the study room.
Study design
The vegetative bacteria were grown on sheep blood agar. Serial dilutions of inocula were 
made with trypticase soy broth (TSB, Remel, Lenexa, KS). The C. difficile spore 
preparation was stored in Dulbecco’s modified Eagle’s medium (HyClone, Logan, UT), and 
serial dilutions were similarly made using TSB. The 4 test organisms were C. difficile spores 
(BI strain), a MRSA strain (ATCC 43300), a VRE strain (ATCC strain 51299), and a clinical 
isolate of MDR Acinetobacter baumannii. Rodac plate templates were drawn on the Formica 
sheet and inoculated with 10–15 µL of a 104 dilution of test organisms suspended in TSB, 
producing an estimated inoculum of 100–500 test organisms. After inoculation, each surface 
was allowed to air dry for 10 minutes after inoculation. Once dry, the test Formica sheets 
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were exposed to the disinfecting light and triplicate samples were collected with Rodac 
plates containing Dey-Engley Neutralizing Agar after 0, 1, 3, 5, 6, 7, 24, 48, and 72 hours. 
These plates were then incubated based on the test organism being studied (aerobically at 
37°C for 48 hours for bacteria and anaerobically at 37°C for 48 hours for C. difficile) in an 
AnaeroPack anaerobic gas generator (Anaeropack, Mitsubishi Gas Chemical, Tokyo, Japan). 
After incubation, the colony-forming units (CFU) of the test organisms on each plate were 
quantified. Each template area was sampled only once. Surfaces were maintained at ambient 
room temperature and relative humidity. A control Formica sheet was placed in an adjacent 
area but not exposed to the HINS light to accommodate the expected natural in vitro die-off 
of vegetative bacteria. Triplicate samples were collected with Rodacs at the same test times 
as the test surfaces. Two experimental runs were conducted for all time points.
Statistical methods
We fit a mixed-effects negative binomial model to the data using the R statistical software8 
and the lme4 package.9 We modeled the “blue” light as augmenting the “white” light. Both 
linear and squared time variables were included in the model to account for any nonlinear 
effects. The full model began with a 3-way interaction of treatment × bacteria × time, and 
hypotheses were tested using likelihood ratio tests of progressively nested models. A P value 
< .05 was considered significant.
Results
A 3-way interaction was significant (χ2 = 265.5; df = 12; P < .001), indicating that the effect 
of the type of light treatment differed with different combinations of test organisms and 
time. The treatment (ie, both blue and white light) had significantly different rates of 
pathogen killing over time for all 4 organisms: Acinetobacter (χ2 = 117.2; df = 4; P < .001), 
MRSA (χ2 = 80.5; df = 4; P < .001), VRE (χ2 = 150.4; df = 4; P < .001), and C. difficile 
(χ2 = 25.8; df = 4; P < .001).
We also performed individual tests of the interactions between the white (vs the control) and 
time, and blue (vs white) and time. Both types of light treatments were associated with more 
rapid decreases in observed bacterial counts over time with all 4 organisms with 1 exception, 
the use of white light had no effect on C. difficile compared to control (Fig. 1). Specifically, 
the number of CFUs on test Rodac plates decreased over time for Acinetobacter with the 
white light (χ2 = 95.7; df = 2; P < .001) and the blue light (χ2 = 16.6; df = 2; P < .001); for 
MRSA, for both white (χ2 = 31.7; df = 2; P < .001) and blue (χ2 = 29.9; df = 2; P < .001); 
and for VRE, for both white (χ2 = 7.1; df = 2; P < .029) and blue (χ2 = 138.5; df = 2; P < .
001). However, white was not superior to control for C. difficile (χ2 = 2.6; df = 2; P = .20), 
but the use of blue light increased killing of C. difficile (χ2 = 23.9; df = 2; P < .001).
Table 1 lists the earliest hour by which our statistical model predicted a sustained reduction 
in the number of CFUs by a given percentage. Overall, the model demonstrates enhanced 
inactivation of pathogens with the “blue” and “white” light.
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Discussion
The use of light disinfection technology for continuous disinfection of the healthcare 
environment has been proposed by various investigators.5–7 The use of disinfecting lights, if 
effective, could augment the episodic disinfection (eg, daily) that occurs in patient rooms or 
care areas by preventing or reducing the microbial regrowth on surfaces following 
disinfection, and by reducing the microbial level due to recontamination. These light sources 
are thought to be safe for surfaces and for humans,7 although there has been limited human 
experience.
We demonstrated that the “blue” and “white” light significantly reduced the 3 vegetative test 
bacteria; and “blue” light yielded lower counts of C. difficile spores after 72 hours. Whether 
the level of these reductions are sufficient to reduce healthcare-associated infections remains 
uncertain, and the question requires further study.
This study was a preliminary evaluation. Future studies will need to consider cost-
effectiveness, multiple types of surfaces (eg, porous vs nonporous surfaces, stainless steel) 
with taxonomically diverse pathogens (eg, norovirus, Enterobacteriaceae) to include spores, 
use areas (eg, operating room), and the ability of the technology to continuously reduce the 
overall bioburden in inpatient and outpatient care areas and reduce HAIs. A separate issue is 
the acceptance of continuous light (ie, 24 hours) by patients and staff. If shorter durations of 
continuous light exposure are deemed necessary, the level of decontamination achieved by 
use during times when the patient is awake (eg, ~ 16 hours per day) needs further study. In 
addition, future studies should include rechallenging the surfaces with additional 
contamination (eg, every 4–6 hours). Given that environmental surfaces in a patient’s room 
are often not thoroughly disinfected and that recontamination occurs rapidly, it is important 
to develop either methods of continuous disinfection or a germicide with persistant 
antimicrobial effectiveness.
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Fig. 1. 
Use of a continuous visible light disinfection system and predicted reduction (CFU/mL) in 
epidemiological important pathogens over time. Under the “blue,” “white,” and control 
lights, the models predicted the number of colony-forming units of (A) vancomycin-resistant 
Enterococcus-VRE, (B) C. difficile, (C) MDR-Acinetobacter, and (D) methicillin-resistant 
S. aureus-MRSA (see Methods). The curves are drawn continuously over the temporal 
interval from 0 to 72 hours. However, in the experiment, the actual time points when the 
CFUs were counted were at 0, 1, 3, 5, 6, 7, 24, 48, and 72 hours. Because the model treats 
time as continuous, we were able to calculate predicted values for any time point between 0 
and 72.
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